Chemical Structure : FHD-286
CAS No.: 2671128-05-3
Catalog No.: PC-73320Not For Human Use, Lab Use Only.
FHD-286 (FHD286) is a highly potent, selective, allosteric and orally available inhibitor of BRG1 (SMARCA4)/BRM (SMARCA2), dual BRM/ BRG1 inhibitor.
Packing | Price | Stock | Quantity |
---|---|---|---|
1 mg | $158 | In stock | |
5 mg | $298 | In stock | |
10 mg | $478 | In stock | |
25 mg | $728 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
FHD-286 (FHD286) is a highly potent, selective, allosteric and orally available inhibitor of BRG1 (SMARCA4)/BRM (SMARCA2), dual BRM/ BRG1 inhibitor.
FHD-286 is a novel BAF (BAF (BRG1/BRM-Associated Factor) inhibitor for the treatment of acute myeloid leukemia (AML), Myelodysplastic syndromes (MDS) and metastatic uveal melanoma (UM).
M.Wt | 562.660 | |
Formula | C24H30N6O6S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-((S)-1-((4-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-2-yl)thiazol-2-yl)amino)-3-methoxy-1-oxopropan-2-yl)-1-(methylsulfonyl)-1H-pyrrole-3-carboxamide |
1. Warren C. Fiskus, et al. Cancer Res (2023) 83 (7_Supplement): 1140.
2. Fiskus W, et al. Blood. 2024 May 16;143(20):2059-2072.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright